Stay updated on Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice and Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T01:19:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page adds a government funding and operating status notice and updates the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:16:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary display was added and the page revision updated to v3.4.0. Metadata labels about QC updates and No FEAR Act data were adjusted (the new terms added, old ones removed).
    Difference
    0.2%
    Check dated 2026-01-28T07:31:09.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. No substantive changes to the study details page.
    Difference
    0.0%
    Check dated 2026-01-14T04:00:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as a trial site, replacing the old Texas Locations label. The HHS Vulnerability Disclosure link was removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:57:40.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision indicator changed from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:32:57.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.